ER Evaluation Tool for Health Impairment in Seniors

Age: 65+

Sex: Any

Trial Phase: Academic

Sponsor: Jewish General Hospital

Disqualifiers: Age 74 or less

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 2

5000 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This study evaluates the association between risk levels (i.e.; low, moderate and high) of Emergency Room Tool (ER2) and length of stay in older Emergency Room Tool (ER) users admitted to the medical or surgery wards of the Jewish General Hospital.

Who Is on the Research Team?

Olivier Beauchet, MD

Principal Investigator

Jewish General Hospital

Are You a Good Fit for This Trial?

This trial is for individuals aged 75 and older who have had an unplanned visit to the Emergency Department (ED) and are on a stretcher. It's not open to anyone younger than 75.

Inclusion Criteria

I had an unexpected visit to the ER and was on a stretcher.

I am 75 years old or older.

Exclusion Criteria

I am 74 years old or younger.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

24 hours

1 visit (in-person)

Evaluation

Patients are evaluated using the Emergency Room Evaluation Tool (ER2) to assess risk levels and usability of the tool

24 hours

1 visit (in-person)

Follow-up

Participants are monitored for short-term adverse events and length of hospital stay

30 days

What Are the Treatments Tested in This Trial?

Interventions

• Emergency Room Evaluation Tool (ER2)

Trial Overview The study is testing the ER2, which is an evaluation tool used in the ED. The goal is to see how different risk levels assigned by this tool relate to the length of hospital stay for seniors admitted from the ED.

How Is the Trial Designed?

Group I: Emergency Room Evaluation Tool (ER2) Experimental Treatment 1 Intervention

Patients who are 75 years and over, and who are brought to Emergency in stretchers will be evaluated based on the Emergency Room Evaluation Tool (ER2).

Who Is Running the Clinical Trial?

Jewish General Hospital

Lead Sponsor

Trials

144

Recruited

283,000+